Ciao everyone and Happy World Alzheimers Month!!! For the launch today I recorded a video share it if you can, we have subtitles in a huge number if languages! It’s on You Tube at youtu.be/q7cuA66Tit4 #AskAboutDementia and #AskAboutAlzheimers in your online Access the toolkits at: bit.ly/411i4iC

ADI is pleased to announce that abstract submissions for the upcoming Global Conference of ADI in 2026 are now open! Submit an abstract to showcase your work or research at this international event: bit.ly/4dF5nPr #ADI2026 #GlobalConferenceOfADI #Lyon #DementiaConference #Dementia

ADI’s newest report, From Plan to Impact report 2025 is NOW AVAILABLE for download on our website! Access the report: bit.ly/3ElAgez #Dementia #DementiaPolicy #WorldHealthAssembly #WHO #WorldHealthOrganization #WHA78 #FromPlanToImpact

Learn more about the ongoing debate on the regulatory process for the new treatments for #Alzheimer ’s disease in #Europe: www.thelancet.com/journals/lan... #AlzheimersTreatment #Lequembi #Donanemab #AmyloidTreatment #Lecanemab

This year, World Health Assembly is convening for its 78th meeting, a meeting that will include a crucial decision on whether to extend the WHO Global Action Plan on the public health response to dementia. Register for our upcoming From Plan To Impact report launch: bit.ly/4iLrLYV #Dementia

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended against granting the marketing authorisation of #donanemab ( #Kisunla ) in the treatment of the mild dementia stage of Alzheimer’s disease across the EU and EEA. www.ema.europa.eu/en/medicines...

Our trip on the East Coast is yielding much food for thought and reflections. More info on Linked in @alzint.org

Alzheimer's Disease International is concerned about the impact of cuts to international development and research budget to our community and to its work on #dementia and #alzheimers. Read our full call to action to governments and policymakers on our website: www.alzint.org/news-events/...